Daypro and Pregnancy
Although pregnancy and Daypro are generally considered a bad combination, a healthcare provider may recommend the drug if the benefits to the mother outweigh the risks to the fetus. It has not been studied in pregnant humans; however, animal studies show that the drug may cause problems for the fetus. If you are taking this medication and pregnancy occurs, your healthcare provider will consider your particular situation before making a recommendation.
Most healthcare providers do not recommend taking Daypro® (oxaprozin) during pregnancy, because it can cause problems for the unborn child or complicate labor and delivery. Taking Daypro at all during the third trimester should be avoided. Early in the pregnancy, it is possible that your healthcare provider may recommend Daypro if he or she feels that the benefits to you outweigh the risks to the fetus.
Daypro is considered a pregnancy Category C medicine by the U.S. Food and Drug Administration (FDA). The FDA uses a category system to classify the possible risks to a fetus when specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans but show side effects to the fetus in animal studies. However, it is important to note that animals do not always respond to medicines the same way that humans do. A pregnancy Category C medicine may still be given to a pregnant woman if the healthcare provider believes that the benefits to the mother outweigh the risks to the unborn child.
If you are pregnant or thinking of becoming pregnant while taking Daypro, let your healthcare provider know. He or she will consider the benefits and risks before making a recommendation for your particular situation.